How GLP-1 weight-loss drugs are changing fast-food menus

Fast-food chains like McDonald’s are revamping their menus to cater to customers using GLP-1 weight-loss drugs, which are known to reduce appetite. McDonald’s is introducing healthier, high-protein options such as grilled chicken sandwiches, wraps, and egg bites as part of an $8.5 billion global restaurant overhaul. CEO Chris Kempczinski emphasized the need to evolve the menu to meet future consumer demands. Skye Anderson, president of McDonald’s USA, highlighted the importance of offering more protein and flexible portions to satisfy changing eating habits. Other chains, like Shake Shack and Chipotle, are also adapting their menus to support weight management goals, offering items like lettuce-wrapped burgers and low-calorie bowls. Research indicates that households with GLP-1 users reduce spending at fast-food outlets, prompting these chains to diversify their offerings to remain relevant. QUESTION: How might the shift towards healthier fast-food options influence the eating habits of future generations?